Skepticism and Surprises in the Ad Com Meeting

Examining the accelerated approval process and highlighting uncertainties through a comparison of the drug in question to another on the market, with surprising rejection faced by a well-established company.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app